GABA-Based Evaluation of Neurologic Conditions: MR Spectroscopy

References

1. 1.↵
   1. Roberts E,
   2. Baxter CF

   . Metabolic studies of gamma-aminobutyric acid. Neurology 1958;8(suppl 1):77–78

   FREE Full Text
2. 2.↵
   1. Roberts E,
   2. Rothstein M,
   3. Baxter CF

   . Some metabolic studies of gamma-aminobutyric acid. Proc Soc Exp Biol Med 1958;97:796–802

   Abstract/FREE Full Text
3. 3.↵
   1. Defelipe J

   . Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell-surface molecules. Cerebral Cortex 1993;3:273–89

   Abstract/FREE Full Text
4. 4.↵
   1. Chang L,
   2. Cloak CC,
   3. Ernst T

   . Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry 2003;64(suppl 3):7–14
5. 5.↵
   1. Doelken MT,
   2. Hammen T,
   3. Bogner W,
   4. et al

   . Alterations of intracerebral gamma-aminobutyric acid (GABA) levels by titration with levetiracetam in patients with focal epilepsies. Epilepsia 2010;51:1477–82

   CrossRefPubMed
6. 6.↵
   1. Rothman DL,
   2. Petroff OA,
   3. Behar KL,
   4. et al

   . Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A 1993;90:5662–66

   Abstract/FREE Full Text
7. 7.↵
   1. Bonavita S,
   2. Di Salle F,
   3. Tedeschi G

   . Proton MRS in neurological disorders. Eur J Radiol 1999;30:125–31

   CrossRefPubMedWeb of Science
8. 8.↵
   1. Goto N,
   2. Yoshimura R,
   3. Moriya J,
   4. et al

   . Critical examination of a correlation between brain gamma-aminobutyric acid (GABA) concentrations and a personality trait of extroversion in healthy volunteers as measured by a 3 Tesla proton magnetic resonance spectroscopy study. Psychiatry Res 2010;182:53–57

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Jensen JE,
   2. Frederick BD,
   3. Wang L,
   4. et al

   . Two-dimensional, J-resolved spectroscopic imaging of GABA at 4 Tesla in the human brain. Magn Reson Med 2005;54:783–88

   CrossRefPubMed
10. 10.↵
    1. Jensen JE,
    2. Frederick Bde B,
    3. Renshaw PF

    . Grey and white matter GABA level differences in the human brain using two-dimensional, J-resolved spectroscopic imaging. NMR Biomed 2005;18:570–76

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Keltner JR,
    2. Wald LL,
    3. Frederick BD,
    4. et al

    . In vivo detection of GABA in human brain using a localized double-quantum filter technique. Magn Reson Med 1997;37:366–71

    CrossRefPubMed
12. 12.↵
    1. Choi C,
    2. Bhardwaj PP,
    3. Kalra S,
    4. et al

    . Measurement of GABA and contaminants in gray and white matter in human brain in vivo. Magn Reson Med 2007;58:27–33

    CrossRefPubMed
13. 13.↵
    1. Choi IY,
    2. Lee SP,
    3. Shen J

    . In vivo single-shot three-dimensionally localized multiple quantum spectroscopy of GABA in the human brain with improved spectral selectivity. J Magn Reson 2005;172:9–16

    CrossRefPubMed
14. 14.↵
    1. Choi IY,
    2. Lee SP,
    3. Merkle H,
    4. et al

    . Single-shot two-echo technique for simultaneous measurement of GABA and creatine in the human brain in vivo. Magn Reson Med 2004;51:1115–21

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Snyder J,
    2. Hanstock CC,
    3. Wilman AH

    . Spectral editing of weakly coupled spins using variable flip angles in PRESS constant echo time difference spectroscopy: application to GABA. J Magn Reson 2009;200:245–50

    CrossRefPubMed
16. 16.↵
    1. Shen J

    . Slice-selective J-coupled coherence transfer using symmetric linear phase pulses: applications to localized GABA spectroscopy. J Magn Reson 2003;163:73–80

    CrossRefPubMed
17. 17.↵
    1. Waddell KW,
    2. Avison MJ,
    3. Joers JM,
    4. et al

    . A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging 2007;25:1032–38. Epub 2007 Feb 2

    CrossRefPubMed
18. 18.↵
    1. Henry ME,
    2. Lauriat TL,
    3. Shanahan M,
    4. et al

    . Accuracy and stability of measuring GABA, glutamate, and glutamine by proton magnetic resonance spectroscopy: a phantom study at 4 Tesla. J Magn Reson 2011;208:210–18

    CrossRefPubMed
19. 19.↵
    1. Ke Y,
    2. Cohen BM,
    3. Bang JY,
    4. et al

    . Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res 2000;100:169–78

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Ryner LN,
    2. Sorenson JA,
    3. Thomas MA

    . 3D localized 2D NMR-spectroscopy on an MRI scanner. J Magn Reson Series B 1995;107:126–37

    CrossRefPubMed
21. 21.↵
    1. Ryner LN,
    2. Sorenson JA,
    3. Thomas MA

    . Localized 2D J-resolved 1H MR spectroscopy: strong coupling effects in vitro and in vivo. Magn Reson Imaging 1995;13:853–69

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Edden RA,
    2. Barker PB

    . Spatial effects in the detection of gamma-aminobutyric acid: improved sensitivity at high fields using inner volume saturation. Magn Reson Med 2007;58:1276–82

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Edden RA,
    2. Barker PB

    . If J doesn't evolve, it won't J-resolve: J-PRESS with bandwidth-limited refocusing pulses. Magn Reson Med 2011;65:1509–14

    CrossRefPubMed
24. 24.↵
    1. Donahue MJ,
    2. Near J,
    3. Blicher JU,
    4. et al

    . Baseline GABA concentration and fMRI response. Neuroimage 2010; 53:392–98

    CrossRefPubMed
25. 25.↵
    1. Northoff G,
    2. Walter M,
    3. Schulte RF,
    4. et al

    . GABA concentrations in the human anterior cingulate cortex predict negative BOLD responses in fMRI. Nat Neurosci 2007;10:1515–17

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Muthukumaraswamy SD,
    2. Edden RA,
    3. Jones DK,
    4. et al

    . Resting GABA concentration predicts peak gamma frequency and fMRI amplitude in response to visual stimulation in humans. Proc Natl Acad Sci U S A 2009;106:8356–61

    Abstract/FREE Full Text
27. 27.↵
    1. Levy LM,
    2. Ziemann U,
    3. Chen R,
    4. et al

    . Rapid modulation of GABA in sensorimotor cortex induced by acute deafferentation. Ann Neurol 2002;52:755–61

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Yamamoto M,
    2. Takahashi S,
    3. Otsuki S,
    4. et al

    . GABA levels in cerebrospinal fluid of patients with epilepsy. Folia Psychiatr Neurol Jpn 1985;39:515–19

    PubMed
29. 29.↵
    1. McKnight K,
    2. Jiang Y,
    3. Hart Y,
    4. et al

    . Serum antibodies in epilepsy and seizure-associated disorders. Neurology 2005;65:1730–36

    Abstract/FREE Full Text
30. 30.↵
    1. Peltola J,
    2. Kulmala P,
    3. Isojarvi J,
    4. et al

    . Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 2000;55:46–50

    Abstract/FREE Full Text
31. 31.↵
    1. Stagg CJ,
    2. Lang B,
    3. Best JG,
    4. et al

    . Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels. Epilepsia 2010;51:1898–901

    CrossRefPubMedWeb of Science
32. 32.↵
    1. Petroff OA,
    2. Rothman DL,
    3. Behar KL,
    4. et al

    . Low brain GABA level is associated with poor seizure control. Ann Neurol 1996;40:908–11

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Petroff OA,
    2. Hyder F,
    3. Rothman DL,
    4. et al

    . Homocarnosine and seizure control in juvenile myoclonic epilepsy and complex partial seizures. Neurology 2001;56:709–15

    Abstract/FREE Full Text
34. 34.↵
    1. Petroff OA,
    2. Behar KL,
    3. Rothman DL

    . New NMR measurements in epilepsy: measuring brain GABA in patients with complex partial seizures. Adv Neurol 1999;79:939–45

    PubMed
35. 35.↵
    1. Simister RJ,
    2. McLean MA,
    3. Barker GJ,
    4. et al

    . Proton MR spectroscopy of metabolite concentrations in temporal lobe epilepsy and effect of temporal lobe resection. Epilepsy Res 2009;83:168–76

    CrossRefPubMed
36. 36.↵
    1. Simister RJ,
    2. McLean MA,
    3. Barker GJ,
    4. et al

    . Proton MRS reveals frontal lobe metabolite abnormalities in idiopathic generalized epilepsy. Neurology 2003;61:897–902

    Abstract/FREE Full Text
37. 37.↵
    1. Simister RJ,
    2. McLean MA,
    3. Barker GJ,
    4. et al

    . Proton magnetic resonance spectroscopy of malformations of cortical development causing epilepsy. Epilepsy Res 2007;74:107–15

    CrossRefPubMedWeb of Science
38. 38.↵
    1. Taki MM,
    2. Harada M,
    3. Mori K,
    4. et al

    . High gamma-aminobutyric acid level in cortical tubers in epileptic infants with tuberous sclerosis complex measured with the MEGA-editing J-difference method and a three-Tesla clinical MRI instrument. Neuroimage 2009;47:1207–14

    CrossRefPubMedWeb of Science
39. 39.↵
    1. Aasly J,
    2. Silfvenius H,
    3. Aas TC,
    4. et al

    . Proton magnetic resonance spectroscopy of brain biopsies from patients with intractable epilepsy. Epilepsy Res 1999;35:211–17

    CrossRefPubMedWeb of Science
40. 40.↵
    1. Petroff OA,
    2. Pleban LA,
    3. Spencer DD

    . Symbiosis between in vivo and in vitro NMR spectroscopy: the creatine, N-acetylaspartate, glutamate, and GABA content of the epileptic human brain. Magn Reson Imaging 1995;13:1197–211

    CrossRefPubMedWeb of Science
41. 41.↵
    1. Petroff OA,
    2. Rothman DL,
    3. Behar KL,
    4. et al

    . Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain. Epilepsia 1995; 36:457–64

    CrossRefPubMed
42. 42.↵
    1. Levy LM,
    2. Levy-Reis I,
    3. Fujii M,
    4. et al

    . Brain gamma-aminobutyric acid changes in stiff-person syndrome. Arch Neurol 2005;62:970–74

    CrossRefPubMedWeb of Science
43. 43.↵
    1. Dalakas MC,
    2. Fujii M,
    3. Li M,
    4. et al

    . The clinical spectrum of anti-GAD antibody-positive patients with stiff-person syndrome. Neurology 2000; 55:1531–35

    Abstract/FREE Full Text
44. 44.↵
    1. Dalakas MC,
    2. Li M,
    3. Fujii M,
    4. et al

    . Stiff person syndrome: quantification, specificity, and intrathecal synthesis of GAD65 antibodies. Neurology 2001;57:780–84

    Abstract/FREE Full Text
45. 45.↵
    1. Murinson BB,
    2. Butler M,
    3. Marfurt K,
    4. et al

    . Markedly elevated GAD antibodies in SPS: effects of age and illness duration. Neurology 2004;63:2146–48

    Abstract/FREE Full Text
46. 46.↵
    1. Levy LM,
    2. Hallett M

    . Impaired brain GABA in focal dystonia. Ann Neurol 2002;51:93–101

    CrossRefPubMedWeb of Science
47. 47.↵
    1. Quartarone A,
    2. Siebner HR,
    3. Rothwell JC

    . Task-specific hand dystonia: can too much plasticity be bad for you? Trends Neurosci 2006;29:192–99

    CrossRefPubMedWeb of Science
48. 48.↵
    1. Taylor M,
    2. Bhagwagar Z,
    3. Cowen PJ,
    4. et al

    . GABA and mood disorders. Psychol Med 2003;33:387–93

    CrossRefPubMed
49. 49.↵
    1. Hasler G,
    2. van der Veen JW,
    3. Tumonis T,
    4. et al

    . Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 2007;64:193–200

    CrossRefPubMedWeb of Science
50. 50.↵
    1. Sanacora G,
    2. Mason GF,
    3. Rothman DL,
    4. et al

    . Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999;56:1043–47

    CrossRefPubMedWeb of Science
51. 51.↵
    1. Bhagwagar Z,
    2. Wylezinska M,
    3. Jezzard P,
    4. et al

    . Low GABA concentrations in occipital cortex and anterior cingulate cortex in medication-free, recovered depressed patients. Int J Neuropsychopharmacol 2008;11:255–60

    Abstract/FREE Full Text
52. 52.↵
    1. Cotter D,
    2. Landau S,
    3. Beasley C,
    4. et al

    . The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia. Biol Psychiatry 2002;51:377–86

    CrossRefPubMedWeb of Science
53. 53.↵
    1. Berrettini WH,
    2. Nurnberger JI Jr.,
    3. Hare TA,
    4. et al

    . Reduced plasma and CSF gamma-aminobutyric acid in affective illness: effect of lithium carbonate. Biol Psychiatry 1983;18:185–94

    PubMed
54. 54.↵
    1. Goddard AW,
    2. Mason GF,
    3. Almai A,
    4. et al

    . Reductions in occipital cortex GABA levels in panic disorder detected with 1H-magnetic resonance spectroscopy. Arch Gen Psychiatry 2001;58:556–61

    CrossRefPubMedWeb of Science
55. 55.↵
    1. Goddard AW,
    2. Mason GF,
    3. Appel M,
    4. et al

    . Impaired GABA neuronal response to acute benzodiazepine administration in panic disorder. Am J Psychiatry 2004;161:2186–93

    CrossRefPubMedWeb of Science
56. 56.↵
    1. Pollack MH,
    2. Jensen JE,
    3. Simon NM,
    4. et al

    . High-field MRS study of GABA, glutamate and glutamine in social anxiety disorder: response to treatment with levetiracetam. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:739–43

    CrossRefPubMed
57. 57.↵
    1. Hasler G,
    2. van der Veen JW,
    3. Grillon C,
    4. et al

    . Effect of acute psychological stress on prefrontal GABA concentration determined by proton magnetic resonance spectroscopy. Am J Psychiatry 2010;167:1226–31

    CrossRefPubMedWeb of Science
58. 58.↵
    1. Hashimoto T,
    2. Bazmi HH,
    3. Mirnics K,
    4. et al

    . Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 2008;165:479–89

    CrossRefPubMedWeb of Science
59. 59.↵
    1. Yoon JH,
    2. Maddock RJ,
    3. Rokem A,
    4. et al

    . GABA concentration is reduced in visual cortex in schizophrenia and correlates with orientation-specific surround suppression. J Neurosci 2010;30:3777–81

    Abstract/FREE Full Text
60. 60.↵
    1. Tayoshi S,
    2. Nakataki M,
    3. Sumitani S,
    4. et al

    . GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res 2010;117:83–91

    CrossRefPubMed
61. 61.↵
    1. Krystal JH,
    2. Staley J,
    3. Mason G,
    4. et al

    . Gamma-aminobutyric acid type A receptors and alcoholism: intoxication, dependence, vulnerability, and treatment. Arch Gen Psychiatry 2006;63:957–68

    CrossRefPubMedWeb of Science
62. 62.↵
    1. Addolorato G,
    2. Caputo F,
    3. Capristo E,
    4. et al

    . Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. Alcohol Alcohol 2002; 37:504–08

    Abstract/FREE Full Text
63. 63.↵
    1. Ticku MK

    . Alcohol and GABA-benzodiazepine receptor function. Ann Med 1990;22:241–46

    PubMed
64. 64.↵
    1. Behar KL,
    2. Rothman DL,
    3. Petersen KF,
    4. et al

    . Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 1999;156:952–54

    PubMedWeb of Science
65. 65.↵
    1. Mason GF,
    2. Petrakis IL,
    3. de Graaf RA,
    4. et al

    . Cortical gamma-aminobutyric acid levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry 2006;59:85–93

    CrossRefPubMedWeb of Science
66. 66.↵
    1. Mason G,
    2. Appel M,
    3. de Graaf R,
    4. et al

    . Brain GABA falls by 1 month of detoxification and remains low. Alcohol Clin Exp Res 2003;Suppl(27):56A
67. 67.↵
    1. Ke Y,
    2. Streeter CC,
    3. Nassar LE,
    4. et al

    . Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 2004;130:283–93

    CrossRefPubMedWeb of Science
68. 68.↵
    1. Ke Y,
    2. Streeter CC,
    3. Yurgelun-Todd DA,
    4. et al

    . A J-resolved, two dimensional MRS study of brain GABA and NAA levels in cocaine dependent subjects-before and after treatment. In: Proceedings of the International Society of Magnetic Resonance in Medicine, May 7–13, 2001; Montreal, Quebec, Canada
69. 69.↵
    1. Winkelman JW,
    2. Buxton OM,
    3. Jensen JE,
    4. et al

    . Reduced brain GABA in primary insomnia: preliminary data from 4T proton magnetic resonance spectroscopy (1H-MRS). Sleep 2008;31:1499–506

    PubMed
70. 70.↵
    1. Kakeda S,
    2. Korogi Y,
    3. Moriya J,
    4. et al

    . Influence of work shift on glutamic acid and gamma-aminobutyric acid (GABA): evaluation with proton magnetic resonance spectroscopy at 3T. Psychiatry Res 2011;192:55–59

    CrossRefPubMed
71. 71.↵
    1. Kim SJ,
    2. Lyoo IK,
    3. Lee YS,
    4. et al

    . Increased GABA levels in medial prefrontal cortex of young adults with narcolepsy. Sleep 2008;31:342–47

    PubMedWeb of Science
72. 72.↵
    1. Bigal ME,
    2. Hetherington H,
    3. Pan J,
    4. et al

    . Occipital levels of GABA are related to severe headaches in migraine. Neurology 2008;70:2078–80

    FREE Full Text
73. 73.↵
    1. Fatemi SH,
    2. Folsom TD,
    3. Reutiman TJ,
    4. et al

    . Expression of GABA(B) receptors is altered in brains of subjects with autism. Cerebellum 2009;8:64–69

    CrossRefPubMedWeb of Science
74. 74.↵
    1. Fatemi SH,
    2. Reutiman TJ,
    3. Folsom TD,
    4. et al

    . GABA(A) receptor downregulation in brains of subjects with autism. J Autism Dev Disord 2009;39:223–30

    CrossRefPubMedWeb of Science
75. 75.↵
    1. Harada M,
    2. Taki MM,
    3. Nose A,
    4. et al

    . Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3T instrument. J Autism Dev Disord 2011;41:447–54

    CrossRefPubMed
76. 76.↵
    1. Henkin RI,
    2. Levy LM,
    3. Lin CS

    . Taste and smell phantoms revealed by brain functional MRI (fMRI). J Comput Assist Tomogr 2000;24:106–23

    CrossRefPubMed
77. 77.↵
    1. Levy LM,
    2. Henkin RI

    . Brain gamma-aminobutyric acid levels are decreased in patients with phantageusia and phantosmia demonstrated by magnetic resonance spectroscopy. J Comput Assist Tomogr 2004;28:721–27

    CrossRefPubMed
78. 78.↵
    1. Licata SC,
    2. Jensen JE,
    3. Penetar DM,
    4. et al

    . A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. Psychopharmacology (Berl) 2009;203:819–29. Epub 2009 Jan 6

    CrossRef
79. 79.↵
    1. Mattson RH,
    2. Petroff OA,
    3. Rothman D,
    4. et al

    . Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy. Acta Neurol Scand Suppl 1995;162:27–30

    PubMed
80. 80.↵
    1. Petroff OA,
    2. Rothman DL,
    3. Behar KL,
    4. et al

    . Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 1996;47:1567–71

    Abstract/FREE Full Text
81. 81.↵
    1. Weber OM,
    2. Verhagen A,
    3. Duc CO,
    4. et al

    . Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography. Magn Reson Imaging 1999;17:417–25

    CrossRefPubMedWeb of Science
82. 82.↵
    1. Verhoeff NP,
    2. Petroff OA,
    3. Hyder F,
    4. et al

    . Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS. Epilepsia 1999;40:1433–38

    CrossRefPubMedWeb of Science
83. 83.↵
    1. Petroff OA,
    2. Rothman DL

    . Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin. Mol Neurobiol 1998;16:97–121

    PubMedWeb of Science
84. 84.↵
    1. Mueller SG,
    2. Weber OM,
    3. Duc CO,
    4. et al

    . Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics. Epilepsia 2001;42:29–40
85. 85.↵
    1. Kuzniecky R,
    2. Hetherington H,
    3. Ho S,
    4. et al

    . Topiramate increases cerebral GABA in healthy humans. Neurology 1998;51:627–29

    Abstract/FREE Full Text
86. 86.↵
    1. Moore CM,
    2. Wardrop M,
    3. deB Frederick B,
    4. et al

    . Topiramate raises anterior cingulate cortex glutamine levels in healthy men; a 4.0 T magnetic resonance spectroscopy study. Psychopharmacology (Berl) 2006;188:236–43

    CrossRefPubMed
87. 87.↵
    1. Petroff OA,
    2. Hyder F,
    3. Rothman DL,
    4. et al

    . Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 2001;42:543–48

    CrossRefPubMedWeb of Science
88. 88.↵
    1. Petroff OA,
    2. Hyder F,
    3. Mattson RH,
    4. et al

    . Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology 1999;52:473–78

    Abstract/FREE Full Text
89. 89.↵
    1. Shiah IS,
    2. Yatham LN,
    3. Gau YC,
    4. et al

    . Effect of lamotrigine on plasma GABA levels in healthy humans. Prog Neuropsychopharmacol Biol Psychiatry 2003;27:419–23

    CrossRefPubMed
90. 90.↵
    1. Kuzniecky R,
    2. Ho S,
    3. Pan J,
    4. et al

    . Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults. Neurology 2002;58:368–72

    Abstract/FREE Full Text
91. 91.↵
    1. Petroff OA,
    2. Hyder F,
    3. Rothman DL,
    4. et al

    . Effects of gabapentin on brain GABA, homocarnosine, and pyrrolidinone in epilepsy patients. Epilepsia 2000;41:675–80

    CrossRefPubMedWeb of Science
92. 92.↵
    1. Sanacora G,
    2. Mason GF,
    3. Rothman DL,
    4. et al

    . Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002;159:663–65

    CrossRefPubMedWeb of Science
93. 93.↵
    1. Bhagwagar Z,
    2. Wylezinska M,
    3. Taylor M,
    4. et al

    . Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 2004;161:368–70

    CrossRefPubMedWeb of Science
94. 94.↵
    1. Streeter CC,
    2. Whitfield TH,
    3. Owen L,
    4. et al

    . Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study. J Altern Complement Med 2010;16:1145–52

    CrossRefPubMed
95. 95.↵
    1. Sanacora G,
    2. Gueorguieva R,
    3. Epperson CN,
    4. et al

    . Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 2004;61:705–13

    CrossRefPubMedWeb of Science
96. 96.↵
    1. Manor D,
    2. Rothman DL,
    3. Mason GF,
    4. et al

    . The rate of turnover of cortical GABA from [1-C-13]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA). Neurochem Res 1996;21:1031–41

    PubMedWeb of Science
97. 97.↵
    1. Dager SR,
    2. Corrigan NM,
    3. Richards TL,
    4. et al

    . Research applications of magnetic resonance spectroscopy to investigate psychiatric disorders. Top Magn Reson Imaging 2008;19:81–96

    CrossRefPubMed